Upregulated Circular RNAs in Gastric Cancer: Target Identification and Tools for Therapeutic Intervention
Cancer Genomics - Proteomics · 2026-07 · 23 (4) · 558-587
DOI: 10.21873/cgp.20590 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Genomics - Proteomics, online erschienen am 29.06.2026. Verfasst von Samuele Graziano und 2 weiteren Autor:innen. Beteiligte Einrichtung: Computational Sciences Center of Excellence, F. Hoffmann-La Roche Ltd., Basel, Switzerland. Hauptthemen laut MEDLINE: Stomach Neoplasms, RNA, Circular, Gene Expression Regulation, Neoplastic. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Surveying the literature (PubMed), we have identified upregulated circular RNAs involved in pathogenesis and dissemination of gastric cancer. We have focused on circRNAs that upregulate the following target classes or physiological processes: transmembrane receptors, secreted proteins, RNA metabolism and processing, ubiquitination, WNT signalling, ferroptosis and druggable enzymes. Circular RNAs upregulating targets for approved drugs in GC, such as vascular endothelial growth factor A (VEGF-A) and programmed death-ligand 1 (PD-L1), were identified, validating circRNAs as tools for target identification. We highlight targets and target classes that are frequently affected by circRNAs such as solute carrier (SLC) proteins, subtypes of heterogeneous nuclear RNA (hnRNA), ubiquitin-specific proteases (USPs) and targets related to inhibition of ferroptosis. We also highlight druggable enzymes as targets. We discuss technical issues for inhibition of the identified targets and their corresponding circular RNAs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Computational Sciences Center of Excellence, F. Hoffmann-La Roche Ltd., Basel, Switzerland.
- Computational Sciences Center of Excellence, F. Hoffmann-La Roche Ltd., Basel, Switzerland; weidle49@t-online.de barbara.hoellbacher@roche.com.
- Roche Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany weidle49@t-online.de barbara.hoellbacher@roche.com.
Zitieren
APA
Graziano, S., Höllbacher, B., & Weidle, U. H. (2026). Upregulated Circular RNAs in Gastric Cancer: Target Identification and Tools for Therapeutic Intervention. Cancer Genomics - Proteomics, 23(4), 558-587. https://doi.org/10.21873/cgp.20590
Vancouver
Graziano S, Höllbacher B, Weidle UH. Upregulated Circular RNAs in Gastric Cancer: Target Identification and Tools for Therapeutic Intervention. Cancer Genomics - Proteomics. 2026;23(4):558-587. doi:10.21873/cgp.20590
BibTeX
@article{Graziano2026,
author = {Graziano, Samuele and Höllbacher, Barbara and Weidle, Ulrich H},
title = {Upregulated Circular RNAs in Gastric Cancer: Target Identification and Tools for Therapeutic Intervention},
journal = {Cancer Genomics - Proteomics},
year = {2026},
volume = {23},
number = {4},
pages = {558--587},
doi = {10.21873/cgp.20590}
}
EUVIMED